Curatio Scientia Advisors in collaboration with Armory Hill Advocates releases the “2023 Patient Access: State Legal and Regulatory Environment Survey”

Given the dynamic nature of state government activity we sought to validate the following:

• Patient access to prescription drug therapy is greatly affected by various state and local policy and regulatory parameters.

• There is no formalized process or aggregating compendium, at the state level, specifically monitoring policy and regulatory parameters that impact patient access to, and affordability of, drug therapies.

• Timely insights into legislation and regulations pertaining to patient access, particularly for high-cost drug therapies will enable more effective decisions regarding the patient’s journey and drug product lifecycle.

Please fill in the below information, hit submit and you will be provided a link to download the report.